Sudden ‘cure’ of type two diabetes due to pancreatic insulinoma: A case report

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3079002 27 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Sudden ‘cure’ of type two diabetes due to pancreatic insulinoma: A case report
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Insulinomas are rare tumors of the islet cells of the pancreas and are the most common cause of endogenous hyperinsulinism. Although they usually present with symptoms of hypoglycemia, sometimes they can have vague symptoms. We present the case of a 62-year-old diabetic female who was diagnosed with a large insulinoma after being investigated for the ‘cure’ of her diabetes. We also review the literature regarding insulinomas in patients with diabetic. A 62-year-old, obese woman with type 2 diabetes mellitus was initially investigated for an unexplained normalization of her blood glucose levels after the cessation of antidiabetic medication due to an episode of severe hypoglycemia. She remained without antidiabetics for three months maintaining normoglycemia, and thereafter, she started experiencing frequent but less severe hypoglycemic episodes. She did not change her diet habits or level of activity and did not lose any weight. The patient underwent further investigation with a supervised 72 h fasting test, which resulted in the biochemical diagnosis of endogenous hyperinsulinism. Imaging studies revealed the presence of a large insulinoma in the head of the pancreas. Finally, the patient underwent a pylorus preserving Whipple procedure, which reversed the aforementioned ‘normalization’ of glucose levels and the underlying diabetes mellitus reappeared. Insulinomas are rare tumors causing hypoglycemia. Even more rarely are found in diabetic patients, making the diagnosis more challenging and probably delayed, as the symptoms are masked by the presence of diabetes, thereby leading to a more advanced disease diagnosis. © 2020, Spandidos Publications. All rights reserved.
Έτος δημοσίευσης:
2020
Συγγραφείς:
Nastos, C.
Giannoulopoulos, D.
Dellaportas, D.
Mizamtsidi, M.
Dafnios, N.
Klonaris, N.
Kalogeris, N.
Vryonidou, A.
Περιοδικό:
Molecular and Clinical Oncology
Εκδότης:
Spandidos Publications
Τόμος:
12
Αριθμός / τεύχος:
2
Σελίδες:
174-178
Λέξεις-κλειδιά:
C peptide; chromogranin; glucose; insulin; metformin; pancreatin; pentetreotide in 111; synaptophysin; vildagliptin, adult; Article; blurred vision; body weight loss; case report; clinical article; computer assisted tomography; confusion; consciousness disorder; contrast enhancement; drug withdrawal; exocrine pancreatic insufficiency; fasting; female; glucose blood level; human; hypoglycemia; increased appetite; insulin blood level; insulin infusion; insulinoma; laparotomy; lymphadenopathy; middle aged; non insulin dependent diabetes mellitus; obesity; organ preservation; pancreas calcification; pancreaticoduodenectomy; scintigraphy; weakness
Επίσημο URL (Εκδότης):
DOI:
10.3892/mco.2019.1957
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.